Zobrazeno 1 - 10
of 45
pro vyhledávání: '"R. Gnoni"'
Publikováno v:
Atherosclerosis. 355:175
Autor:
Giulia Pasello, H. Soto Parra, Paolo Andrea Zucali, M. Tiseo, Alessia Ciarrocchi, M. D'Arcangelo, R. Gnoni, Federica Torricelli, Federica Grosso, Carmine Pinto, C. Giovanni Luca, Maria Pagano, M.C. Garassino, M. Larocca, F. Zanelli, Candida Bonelli
Publikováno v:
Journal of Thoracic Oncology. 14:S484-S485
Autor:
Candida Bonelli, Luca Giovanni Ceresoli, Marina Chiara Garassino, Filippo de Marinis, Francesco Grossi, Paolo Andrea Zucali, Nicola Normanno, Alessia Ciarrocchi, Hector Soto Parra, Maria Pagano, Federico Cappuzzo, Paolo Pedrazzoli, Marcello Tiseo, Federica Torricelli, F. Zanelli, Carmine Pinto, R. Gnoni, Federica Grosso, Giulia Pasello
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2948, p 2948 (2020)
Volume 12
Issue 10
Cancers, Vol 12, Iss 2948, p 2948 (2020)
Volume 12
Issue 10
Purpose: Malignant pleural mesothelioma (MPM) is an aggressive cancer. Data are not available in prospective trials on correlations between genetic alterations and outcomes of therapies. In this study, we assessed the genetic profile of MPM patients
Autor:
Maria Di Bartolomeo, Filippo Pietrantonio, Eliana Rulli, Davide Poli, Rosa Berenato, Marta Caporale, Emilio Bajetta, Irene Floriani, E. Bajetta, M. Di Bartolomeo, L. Catena, M. Schiavo, G. Pinotti, I. Proserpio, G. Rosati, R. Bordonaro, S. Cordio, G. Burrafato, A.M. Bochicchio, M. Aieta, N. Fazio, F. Spada, V. Amoroso, G. Marini, H. Soto Parra, G. Novello, B. Massidda, M.T. Ionta, M. Comandè, R. Venezia, A. Bertolini, E. Menatti, L. Zanlorenzi, A. Colombo, A. Iop, S. Bonura, E. Mazza, M. Viganò, A. Ardizzoia, S. Dell'Oro, G. Lo Re, D. Santeufemia, A. Buonadonna, D. Luisi, G. Ucci, G. Di Lucca, A. Bonetti, F. Bergamo, M. Alù, F. Vastola, P. Marchetti, D.C. Corsi, E. Massa, G. Di Pinto, M. Duro, C. Oliani, M. Franchini, A. Inzoli, N. Gebbia, L. Repetto, S. Rota, L. Frontini, R. Labianca, S. Mosconi, A. Quadri, S. De Grossi, P. Bidoli, M.E. Cazzaniga, F. Villa, P. Foa, D. Ferrari, E. Aitini, C. Rabbi, S. Barni, F. Petrelli, M. Giordano, G. Luchena, M. Pirovano, A. Nasisi, V. Catalano, P. Giordani, A. Zaniboni, F. Leone, S. Ferrario, G.D. Beretta, E.T. Menichetti, D. Conte, D. Mari, R. Giannicola, C. Pierantoni, A.G. Luporini, A. Ragazzini, A. Ravaioli, D. Tassinari, M. Nicolini, D. Amadori, G.L. Frassineti, D. Turci, F. Zumaglini, S. Tamberi, A. Piancastelli, G. Cruciani, E. Bejtja, A. Falcone, L. Landi, G. Minuti, M. Cantore, M. Orlandi, A. Mambrini, A. Ciarlo, D. Cavaciocchi, F. Del Monte, S. Ricci, I.M. Brunetti, M. Lencioni, M. Sisani, P. Sozzi, C. Granetto, S. Chiara, A.S. Galetto, A.S. Ribecco, A. DeCensi, L. Ciuffreda, E.E. Baldini, R. Camisa, R. Todeschini, A. Santoro, L. Rimassa, C. Carnaghi, T. Pressiani, C. Boni, E. Rondini, R. Gnoni, F. Di Costanzo, S. Gasperoni, L. Cavanna, M.A. Palladino, R. Mattioli, G. Laici, F. Pucci, M.D. Alessio, I. Bernardini, G. Tomasello, G. Baldino, R. Rossetti, S. Giaquinta, C. Pinto, F. Di Fabio, F.L. Rijas Llimpe, A.A. Brandes, M. Marzola, A.O.G. Rummo Benevento, S. Competiello, V. Montesarchio, A. Rea, B. Daniele, G. Genua, M. Licenziato, R. Casaretti, L. Silvestro, M. Montano, M.G. Sarobba, G. Sanna, G. Filippelli, G. Dima, E. Greco, M. Roselli, D. Natale, G. Condemi, G. Fumi, S. Tafuto, P. Masullo, D. Nitti, A. Marchet, G. Tiberio, G. de Manzoni, S. Nobili, G. Fiorentini, R. Mazzanti, E. Perrotta, C. Carlomagno, A. De Stefano, G. Cartenì, M. Otero
Publikováno v:
Tumori Journal. 102:e15-e19
Purpose Adjuvant chemotherapy improves survival of patients with gastric cancer. Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) was a phase III study comparing sequential FOLFIRI followed by docetaxel/cisplatin v
Autor:
Giulia Pasello, M.C. Garassino, Federica Torricelli, H. Soto Parra, Paolo Andrea Zucali, Candida Bonelli, Federica Grosso, Carmine Pinto, Giovanni Luca Ceresoli, M. Larocca, Maria Pagano, F. Zanelli, Marcello Tiseo, Alessia Ciarrocchi, R. Gnoni
Publikováno v:
Annals of Oncology. 30:v747
Background MPM is an aggressive cancer with poor prognosis. Platinum/pemetrexed regimen is the standard 1°-line chemotherapy (CHT) in advanced disease. Methods The RAMES Study evaluated the 2°-line efficacy of gemcitabine/ramucirumab treatment vs.
Autor:
Franco Nolè, Stefania Kinspergher, Giovanni L. Pappagallo, Francesco Salaroli, Sebastiano Buti, Carmine Pinto, Patrizia Ciammella, Maria Vitale, Salvatore Roberto Bellia, Consuelo Buttigliero, G. Procopio, R. Gnoni, Giorgia Timon, Alessio Bruni, Claudia Mucciarini, Michele Milella, Renzo Mazzarotto, U. De Giorgi, Franco Morelli, Cristina Masini
Publikováno v:
Annals of Oncology. 30:v389
Background NIVO is an anti-programmed cell death-1 (PD-1) monoclonal antibody; it might work even better when combined with SBRT improving clinical outcomes with a phenomenon known as abscopal effect. To date there are limited data on safety profile
Autor:
Maria Pagano, Cristina Masini, Elisa Gasparini, Giuseppe Prati, Emanuela Fantinel, Alessandra Romagnani, Erika Gervasi, Annalisa Berselli, Carmine Pinto, Giovanna Stridi, R. Gnoni, Candida Bonelli, G. Moretti, Maria Banzi
Publikováno v:
Journal of Clinical Oncology. 37:e14156-e14156
e14156 Background: Checkpoint inhibitors in cancer therapy have shown survival benefits in the treatment of several ATs. However, the risk of serious side effects seems greater in certain types of tumors presenting reduced compliance with therapy. Th
Molecular signature in malignant pleural mesothelioma (MPM): Preliminary data of Italian RAMES study
Autor:
R. Gnoni, Paolo Andrea Zucali, Giovanni Luca Ceresoli, Mario Larocca, Luca Boni, Maria Pagano, Carmine Pinto, Marcello Tiseo, Federica Torricelli, Candida Bonelli, Federico Cappuzzo, Federica Grosso, F. Zanelli, Alessia Ciarrocchi
Publikováno v:
Annals of Oncology. 29:viii674
Autor:
Giovanni Luca Ceresoli, Giulia Pasello, F. Zanelli, Luca Boni, Maria Pagano, Federica Grosso, Carmine Pinto, Paolo Andrea Zucali, Federico Cappuzzo, Marcello Tiseo, R. Gnoni, Candida Bonelli
Publikováno v:
Annals of Oncology. 29:viii644
Autor:
Giancarlo Bisagni, Teresa Gamucci, Rodolfo Passalacqua, Francesco Nuzzo, R. Gnoni, Corrado Boni, A. De Matteis, Andrea Ardizzoni, Lucio Crinò, Anna Maria Musolino
Publikováno v:
Cancer Research. 70:P2-17
Background: Docetaxel (T; Taxotere) with capecitabine (X) is active against metastatic breast cancer (MBC); bevacizumab (B) has demonstrated efficacy with taxanes in the first-line setting. This study was conducted to assess the efficacy and safety o